These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18824360)

  • 1. Utility of a patient survey in identifying fluctuations in early stage Parkinson's disease.
    Silburn PA; Mellick GD; Vieira BI; Danta G; Boyle RS; Herawati L
    J Clin Neurosci; 2008 Nov; 15(11):1235-9. PubMed ID: 18824360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations].
    Azulay JP; Durif F; Rogez R; Tranchant C; Bourdeix I; Rerat K
    Rev Neurol (Paris); 2008 Apr; 164(4):354-62. PubMed ID: 18439927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
    Santens P; de Noordhout AM;
    Acta Neurol Belg; 2006 Sep; 106(3):137-41. PubMed ID: 17091617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors associated with the development of motor complications in Parkinson's disease. A study in a Chilean population].
    Juri-Claveria C; Aguirre-M C; Viviani-G P; Chana-Cuevas P
    Rev Neurol; 2007 Jul 16-31; 45(2):77-80. PubMed ID: 17642046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vehicle drivers with Parkinson disease: behavior schedules of a patient sample from the Community of Madrid].
    Giménez-Roldán S; Dobato JL; Mateo D
    Neurologia; 1998 Jan; 13(1):13-21. PubMed ID: 9522578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of clinical progression in Parkinson's disease. A prospective study.
    Schrag A; Dodel R; Spottke A; Bornschein B; Siebert U; Quinn NP
    Mov Disord; 2007 May; 22(7):938-45. PubMed ID: 17415791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.
    García Ruiz PJ; Sesar Ignacio A; Ares Pensado B; Castro García A; Alonso Frech F; Alvarez López M; Arbelo González J; Baiges Octavio J; Burguera Hernández JA; Calopa Garriga M; Campos Blanco D; Castaño García B; Carballo Cordero M; Chacón Peña J; Espino Ibáñez A; Gorospe Onisalde A; Giménez-Roldán S; Granés Ibáñez P; Hernández Vara J; Ibáñez Alonso R; Jiménez Jiménez FJ; Krupinski J; Kulisevsky Bojarsky J; Legarda Ramírez I; Lezcano García E; Martínez-Castrillo JC; Mateo González D; Miquel Rodríguez F; Mir P; Muñoz Fargas E; Obeso Inchausti J; Olivares Romero J; Olivé Plana J; Otermin Vallejo P; Pascual Sedano B; Pérez de Colosía Rama V; Pérez López-Fraile I; Planas Comes A; Puente Periz V; Rodríguez Oroz MC; Sevillano García D; Solís Pérez P; Suárez Muñoz J; Vaamonde Gamo J; Valero Merino C; Valldeoriola Serra F; Velázquez Pérez JM; Yáñez Baña R; Zamarbide Capdepon I
    Mov Disord; 2008 Jun; 23(8):1130-6. PubMed ID: 18442107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations.
    Sato K; Hatano T; Yamashiro K; Kagohashi M; Nishioka K; Izawa N; Mochizuki H; Hattori N; Mori H; Mizuno Y;
    Mov Disord; 2006 Sep; 21(9):1384-95. PubMed ID: 16763980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced life-space of non-professional caregivers to Parkinson's disease patients with increased disease duration.
    Lökk J
    Clin Neurol Neurosurg; 2009 Sep; 111(7):583-7. PubMed ID: 19559520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweating in Parkinsonian patients with wearing-off.
    Pursiainen V; Haapaniemi TH; Korpelainen JT; Sotaniemi KA; Myllylä VV
    Mov Disord; 2007 Apr; 22(6):828-32. PubMed ID: 17357129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor complications in Parkinson disease: clinical manifestations and management.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2008 Mar; 266(1-2):204-15. PubMed ID: 17897677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments.
    Goetz CG; Leurgans S; Hinson VK; Blasucci LM; Zimmerman J; Fan W; Nguyen T; Hsu A
    Mov Disord; 2008 Jul; 23(10):1479-82. PubMed ID: 18512751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Parkinson's disease--time for optimism.
    Yust-Katz S; Sthneer S; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):233-5. PubMed ID: 18294809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.